Tahoe Bio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTahoe Bio
Tahoe Bio logo

Tahoe Bio

0 followers

About Tahoe Bio

Tahoe Bio is a biotechnology company developing foundational AI-driven models of the human cell using gigascale single-cell maps to understand how drug molecules interact with diverse patient biology. Their platform generates hundreds of millions of perturbational single-cell data points to map chemistry’s effects on cells, enabling precision drug discovery for cancer and other diseases. With a focus on virtual cell models and biology-first data, Tahoe Bio aims to accelerate discovery and translation to the clinic, starting from cancer. The company is based in South San Francisco, California, and has publicly announced open-source data initiatives and partnerships to advance biological AI research.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Nima Alidoust

CEO

Key Facts

HQ Location

South San Francisco, United States

Founded

2022

Employees

11 - 50

Status

Private

Website

https://tahoebio.ai